These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24334210)

  • 1. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data.
    Damman K; Tang WH; Felker GM; Lassus J; Zannad F; Krum H; McMurray JJ
    J Am Coll Cardiol; 2014 Mar; 63(9):853-71. PubMed ID: 24334210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
    Pan L; Payne J; Clark M
    J Okla State Med Assoc; 2011 Feb; 104(2):49-50. PubMed ID: 21815321
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
    Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the renin angiotensin system in dialysis patients.
    Cravedi P; Remuzzi G; Ruggenenti P
    Semin Dial; 2011; 24(3):290-7. PubMed ID: 21682771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic heart failure with impaired left ventricular function (systolic heart failure)].
    Hőgye M; Forster T
    Orv Hetil; 2012 Dec; 153(51):2021-9. PubMed ID: 23248057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?
    Bangalore S; Kumar S; Messerli FH
    Congest Heart Fail; 2013; 19(3):107-15. PubMed ID: 23241032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.
    Damman K; Voors AA; Hillege HL; Navis G; Lechat P; van Veldhuisen DJ; Dargie HJ;
    Eur J Heart Fail; 2010 Sep; 12(9):974-82. PubMed ID: 20685688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?
    Onuigbo MA
    Nephron Clin Pract; 2011; 118(4):c407-19. PubMed ID: 21389735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What physicians need to know about renal function in outpatients with heart failure.
    Waldum-Grevbo B
    Cardiology; 2015; 131(2):130-8. PubMed ID: 25966919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic systolic heart failure].
    Hasenfuse G; Anker SD
    Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.